• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® CARDIOFORM SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® CARDIOFORM SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Catalog Number GSX0025
Device Problem Patient Device Interaction Problem (4001)
Patient Problem Thrombosis/Thrombus (4440)
Event Date 03/24/2022
Event Type  Injury  
Event Description
It was reported, the physician implanted a 25mm gore® cardioform septal occluder on an unknown date in 2020, to close a patent foramen ovale.A thrombus was noted on the left and right disc of the device.The defect was surgically closed, and the device was removed, sometime in (b)(6) 2022.The surgeon noted that the device had a small part that was not epithelialized."on the left side of the device, the majority of the device was epithelialized, except for an exposed metal ring at the very center of the device." the patient¿s hypercoagulable workups had been unremarkable.The thought is that the patient has an underlying hypercoagulable state that the hospital has no test for.The patient was doing well following the surgery.
 
Manufacturer Narrative
No serial # or other details could be obtained from the hospital the gore® cardioform septal occluder instructions for use states: adverse events associated with the use of the occluder may include but are not limited to: thrombosis or thromboembolic event resulting in clinical sequelae.
 
Event Description
It was reported, the physician implanted a 25mm gore® cardioform septal occluder on an unknown date in 2020, to close a patent foramen ovale.A thrombus was noted on the left and right disc of the device.The defect was surgically closed, and the device was removed on (b)(6) 2022.The surgeon noted that the device had a small part that was not endothelialized."on the left side of the device, the majority of the device was epithelialized, except for an exposed metal ring at the very center of the device." the patient¿s hypercoagulable workups had been unremarkable.The thought is that the patient has an underlying hypercoagulable state that the hospital has no test for.The patient was doing well following the surgery.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® CARDIOFORM SEPTAL OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
KENDRICK PEAK MPD B/P
4250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
dan kitterman
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key14240609
MDR Text Key290453449
Report Number2017233-2022-02889
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P050006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/17/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/28/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberGSX0025
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/10/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient SexFemale
-
-